The aim of this study was to compare the proliferative pattern of dentinogenic ghost cell tumors (DGCT) and unicystic calcifying cystic odontogenic tumors (UCCOT) using antibodies against PCNA, p53 and Ki-67. Three cases diagnosed as DGCT and ten as UCCOT were retrieved from the fi les of the Surgical Oral Pathology Service at the University of São Paulo, Brazil. Immunohistochemistry was performed in formalin-fi xed and paraffi n-embedded tissue specimens. Only nuclear staining was considered specifi c for the three antibodies. Immunoexpression of PCNA, Ki-67 and p53 was analyzed semi-quantitatively and quantitatively. The results showed that PCNA was positive in both lesions, mainly in the basal cells, and p53 showed positivity in all cases. UCCOT showed statistically signifi cantly higher Ki-67 labeling indices than did DGCT. In conclusion, our results do not support the correlation between proliferative activity as shown by these proteins and reported biologic behavior.
1
Thus, CCOT was defined as a benign cystic neoplasm of odontogenic origin, characterized by an ameloblastoma-like epithelium with ghost cells that may calcify, 1 and DGCT was defined as a lo- The CCOT is an uncommon benign odontogenic lesion that was first described by Gorlin et al. in 1962. 4 In spite of being called cyst, there is no consensus in the literature as to its classification as a cyst or tumor. 5 Histologically, the cyst wall is lined by a thin ameloblastic epithelium and eosinophilic cells with no obvious nuclei, called "ghost cells," which in turn may be calcified. In the adjacent fibrous area, epithelial proliferation and odontogenic dysplastic dentin can be observed. 6 The DGCT is a rare odontogenic epithelial neoplasm considered the neoplastic counterpart of CCOT. 7 Histologically, the presence of ghost cells within the proliferating ameloblastic epithelium is the essential feature for diagnosis. Varying amounts of dysplastic dentin are present in the surrounding stroma, as well as in close contact with the epithelial islands or ghost cells. In addition, dysplastic calcifications can be found. 8 The study of oncogenes and tumor suppressor genes such as p53, which are involved in the checkpoints of cell growth, can improve understanding of the biological behavior of DGCT.
PCNA (proliferating cell nuclear antigen) is a non-histone nuclear protein required for DNA synthesis and is an accessory protein for DNA polymerase-alpha, which is found at high levels during the G1/S cell cycle. It is synthesized in the cell nucleus and has a key role in cell cycle initiation.
PCNA is the protein most used to evaluate cell proliferation immunohistochemically, since it is undetectable in cells that are out of the cell cycle. The incidence of PCNA expression is correlated with mitotic activity.
9,10
The Ki-67 antigen is expressed in all phases of the cell cycle, except G0. Its expression rises with progression of the cell cycle, increasing during the second half of the S phase, reaching a peak in G2 and M and decreasing rapidly after mitosis. Thus the expression of Ki-67 reflects the number of proliferating cells in a tissue. 11 Non-dividing or "resting" cells in the G0 phase are Ki-67 antigen negative. 9 The p53 protein consists of a tetramer that is accumulated in the cytoplasm during the G1 phase of the cell cycle and migrates to the nucleus in the early S phase, which occurs at one important checkpoint in the cell's DNA. When the DNA molecule has been damaged or the cell is in a stress condition, there is an overexpression of the p53 protein.
In the nucleus, p53 acts as a transcription factor to activate several genes. When it is not possible to correct errors in the DNA molecule, p53 activates pathways inducing apoptosis.
objectIve
The objective of the present study was to evaluate the proliferative activity of DGCT comparing it to that of CCOT using PCNA, p53 and Ki-67. basal cells of the odontogenic epithelium ( Figure   2B ), while p53 showed positivity in all cases (Figure 2C) , as did Ki-67 ( Figure 2D ). Table 1 shows the score grading of DGCT for the immunoreactions with each antibody and Table 2 shows the same for CCOT. CCOT accounts for 1%-2% of all odontogenic tumors, whereas 2%-14% are classified as DGCT.
14 These lesions are characterized by a well-delineated cystic proliferation of the odontogenic epithelium with ghost cells, which are degenerated epithelial cells, usually calcified. It is known that this calcification of odontogenic epithelium is dystrophic. However, dentinoid or bone-like hard tissues have sometimes been reported to be formed in the cyst wall. 15 The solid counterpart of CCOT is more aggressive and is not compatible with a cyst, tending to local recurrence after curettage. 16 DGCT is an odontogenic epithelial neoplasm, considered the neoplastic counterpart of CCOT for being locally aggressive. 
and Ki-67 in these tumors, showing that the expression of Ki-67 was also slightly positive in cases of GCOC, not only in cases of CCOT and DGCT.
In contrast to the present study that did not show any difference for the immunoexpression of p53 and PCNA in the studied cases, Saghafi et al. The explanation for the high PCNA expression and low expression of Ki-67, both proliferation markers, is that PCNA expression can be correlated with mitotic activity, 9,10 while Ki-67 decreases rapidly after mitosis. Therefore, we believe that the increased activity of these tumors occurs soon after the process of mitosis.
conclusIons
In conclusion, our results show that both tumors had the same benign behavior and our findings do not support a correlation between proliferative activity as shown by these proteins and reported biologic behavior.
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